Investor Press releases 2021-12-01 Medivir presents at Erik Penser Bank's Theme Day - Life Science READ MORE 2021-11-18 Results published from trial-initiated Phase II clinical trial of remetinostat in patients with squamous cell carcinoma READ MORE 2021-11-11 Medivir presents at Redeye Life Science Day READ MORE READ ALL PRESS RELEASES Event 2022-02-15 Year-end report, January - December 2021 READ MORE 2022-04-28 Interim report, January - March 2022 READ MORE 2022-05-05 Annual General Meeting 2022 READ MORE SEE ALL EVENTS Presentations VIEW ALL PRESENTATIONS Reports VIEW ALL REPORTS Corporate governance Collected documentation on corporate governance. READ MORE Post Medivir AB Box 1086 SE-141 22 Huddinge Visiting address: Lunastigen 5, 2 tr Phone +46 (0) 8 546 831 00 Email info@medivir.com Our privacy policy Read more Magnus Christensen Interim Chief Executive Officer and Chief Financial Officer magnus.christensen@medivir.com At medivir.se we use cookies to adapt information and content in the best way for you. By continuing to use our website, you agree to the use of cookies. Read more in our privacy policy . I accept cookies

Annual General Meetings 2020-12-11 2021 2020-03-24 2020 2019-05-09 2019 2018-01-10 2018 2017-05-03 2017 2016-05-03 2016 2015-05-05 2015 2014-05-08 2014 2013-05-06 2013 2012-05-10 2012 2011-05-05 2011 2010-04-29 2010 2009-04-23 2009 2008-04-23 2008 Post Medivir AB Box 1086 SE-141 22 Huddinge Visiting address: Lunastigen 5, 2 tr Phone +46 (0) 8 546 831 00 Email info@medivir.com Our privacy policy Read more Magnus Christensen Interim Chief Executive Officer and Chief Financial Officer magnus.christensen@medivir.com At medivir.se we use cookies to adapt information and content in the best way for you. By continuing to use our website, you agree to the use of cookies. Read more in our privacy policy . I accept cookies